Genetic Technologies
GENE
$2.21
Share price
1.40%
Change (1 day)
108.49%
Change (1 year)
Categories
Genetic Technologies (GENE) - Total debt
Total debt on the balance sheet as of June 2023 : $0.35 M
According to Genetic Technologies's latest financial reports the company's total debt is $0.35 M. A company’s total debt is the sum of all current and non-current debts.
Genetic Technologies - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | $0.35 M | -21.44% |
| 2022-06-30 | $0.44 M | 192.86% |
| 2021-06-30 | $0.15 M | -53.7% |
| 2020-06-30 | $0.33 M | |
| 2019-06-30 | $N/A | |
| 2015-06-30 | $0.01 M | -99.19% |
| 2014-06-30 | $2.35 M | |
| 2013-06-30 | $N/A | -100% |
| 2012-06-30 | $0.01 M | -74.96% |
| 2011-06-30 | $0.07 M | -77.45% |
| 2010-06-30 | $0.32 M | 6.93% |
| 2009-06-30 | $0.3 M | 5.38% |
| 2008-06-30 | $0.28 M | -36.55% |
| 2007-06-30 | $0.45 M | -63.98% |
| 2006-06-30 | $1.24 M | -5.57% |
| 2005-06-30 | $1.32 M | 193.31% |
| 2004-06-30 | $0.45 M | -0.11% |
| 2003-06-30 | $0.45 M | |
| 2002-06-30 | $N/A | -100% |
| 2001-06-30 | $0.07 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 9,899,001.01% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $5.49 B | 1,558,603.71% | 🇺🇸 USA |
 Danaher DHR | $19.53 B | 5,538,429.58% | 🇺🇸 USA |
 LabCorp LH | $5.95 B | 1,687,938.13% | 🇺🇸 USA |
 Compugen CGEN | $1.35 M | 283.01% | 🇮🇱 Israel |
 Neogen NEOG | $0.88 B | 252,072.06% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.15 B | 43,020.92% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $41.84 M | 11,762.65% | 🇺🇸 USA |